← Back to BBLG

Bone Biologics Corp - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 14/08/2026Mar 2026Filed 14/08/2026Sep 2025Filed 14/11/2025Jun 2025Filed 14/08/2026Mar 2025Filed 14/08/2026Sep 2024Filed 14/11/2025Jun 2024Filed 14/11/2025Mar 2024Filed 14/11/2025
−$0.8−$0.8−$0.7−$0.7−$1−$0.9−$0.8−$0.9
−$0.43−$0.43−$0.37−$1.33−$1.92−$14.21−$4.02−$1.31
1.81.81.80.60.50.30.20.7

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.